Darren Hassey

Darren Hassey is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as the Executive Director of Quality at Denali Therapeutics since June 2023, overseeing CMC Quality operations. Previously, Darren held the position of Vice President of Quality and CMC Development at Revance Therapeutics, where responsibilities included comprehensive quality oversight. Additional roles include Vice President of Quality at Wockhardt USA, Senior Director of Quality Operations at Dr. Reddy's Laboratories, and Director of Quality Assurance at AMRI. Early career experience includes leadership roles at Penn Pharmaceutical Services, Catalent Pharma Solutions, and scientific positions within AstraZeneca and GSK. Academic credentials include a DBA focused on Emotional Intelligence and Leadership, an MPhil in Pharmaceutical Sciences, and a BSc in Chemistry, all demonstrating a strong foundation in both scientific and leadership disciplines.